Mizuho Securities Keeps Their Buy Rating on Chemours Company (CC)
In a report released on April 3, John Roberts CFA from Mizuho Securities maintained a Buy rating on Chemours Company, with a price target of $25.00.
Easter Sale - 70% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Roberts CFA covers the Basic Materials sector, focusing on stocks such as TRONOX, Westlake Corporation, and Linde. According to TipRanks, Roberts CFA has an average return of 6.4% and a 57.20% success rate on recommended stocks.
In addition to Mizuho Securities, Chemours Company also received a Buy from Alembic Global’s Hassan Ahmed in a report issued on March 18. However, yesterday, TipRanks – OpenAI reiterated a Hold rating on Chemours Company (NYSE: CC).
Based on Chemours Company’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $1.33 billion and a GAAP net loss of $61 million. In comparison, last year the company earned a revenue of $1.39 billion and had a GAAP net loss of $8 million
Read More on CC:
Disclaimer & DisclosureReport an Issue
- Neutral Outlook on Chemours as Stable Thermal Performance Offsets Titanium Dioxide Uncertainty and Below‑Consensus 2026 EBITDA
- Chemours Completes Major 2034 Senior Notes Refinancing
- Chemours price target raised to $21 from $17 at Mizuho
- Chemours Launches Upsized Senior Notes for Debt Refinancing
- Chemours price target raised to $18 from $14 at Goldman Sachs
